Genotoxicity of bleomycin

Mutation Research/Reviews in Genetic Toxicology

Volumn 257, Issue 2, 1991, Pages 127-143

  Povirk, Lawrence F ^a   Finley Austin, M J ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Blenoxane; Bleomycin, genotoxicity

Indexed keywords

BLEOMYCIN; BLEOMYCIN SULFATE;

ANIMAL CELL; ANIMAL EXPERIMENT; CARCINOGENICITY; CHROMOSOME DAMAGE; CYTOTOXICITY; DNA DAMAGE; DRUG METABOLISM; GENOTOXICITY; MUTAGENICITY; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMAL; BLEOMYCIN; CARCINOGENS; CHROMOSOMES; DNA DAMAGE; HUMAN; MUTAGENESIS; MUTAGENS; SUPPORT, U.S. GOV'T, P.H.S.;

ANIMALIA;

EID: 0000576972     PISSN: 01651110     EISSN: None     Source Type: Journal    
DOI: 10.1016/0165-1110(91)90022-N     Document Type: Review

References (122)

1. Sister chromatid exchanges induced by cancer chemotherapeutic agents in vitro and in vivo: Consideration of the hazard of drugs as possible mutagens and carcinogens causing second malignancies
2. New approaches to mutagenicity studies in animals for carcinogenic and mutagenic agents. II. Clastogenic effects determined in transplacentally treated mouse embryos
3. Bleomycin-resistant cells contain increased bleomycin hydrolase activities
4. Pharmacokinetics of bleomycin in man
5. X-inactivation causes differences in FRAXC∗ CQ22.1 expression: evidence from a twin study of common fragile sites
6. Production of sister chromatid exchanges by various cancer chemotherapeutic agents
7. Assessment of preferential cleavage of an actively transcribed retroviral hybrid gene in murine cells by deoxyribonuclease I, bleomycin, neocarzinostatin, or ionizing radiation
8. Hodgkin's disease the Milan Cancer Institute experience with MOPP and ABVD
9. Mutagenicity of 5-hydroxymethyl-2′-deoxyuridine in mammalian cells
10. Intracellular DNA strand scission and growth inhibition of Ehrlich ascites tumor cells by bleomycins
11. Can MOPP be replaced in the treatment of advanced Hodgkin's disease?
12. Modifications of the effect of bleomycin in the somatic mutation and recombination test in Drosophila melanogaster
13. Microsome-stimulated activation of ferrous bleomycin in the presence of DNA
14. Sister chromatid exchanges in human lymphocytes exposed to single cytotoxic drugs in vivo or in vitro
15. 241Am alpha-particles or bleomycin
16. On the nature of a defect in cells from individuals with Ataxia-Telangiectasia
17. A quantitative comparison of potentially lethal damage repair and the rejoining of interphase chromosome breaks in low passage normal human fibroblasts
18. Inhibition of the genotoxicity of bleomycin by superoxide dismutase
19. Sequence specific cleavage of DNA by the antitumor antibiotics neocarzinostatin and bleomycin
20. Cytogenetical characterization of Chinese hamster ovary X-ray-sensitive mutant cells xrs 5 and xrs 6. III. Induction of cell killing, chromosomal aberrations and sister-chromatid exchanges by bleomycin, mono- and bi-functional alkylating agents
21. The induction of reciprocal translocations in mouse germ cells by chemicals and ionizing radiations I. Dose-response relationships and combined effects of bleomycin with thio-tepa and gamma-rays
22. Specific-locus mutations induced in eukaryotes (especially mammalian cells) by radiation and chemicals: a perspective
23. Induction of somatic and male crossing-over by bleomycin in Drosophila melanogaster
24. Recombinogenic and mutagenic effects of the antitumor antibiotic bleomycin in Aspergillus nidulans
25. Comparison of lethality and chromosomal damage induced by X-rays in synchronized Chinese hamster cells in vitro
26. Micronucleus, chromosome aberration, and small-colony TK mutant analysis to quantitate chromosomal damage in L5178Y mouse lymphoma cells
27. Investigations into sister chromatid exchange in patients under cytostatic therapy
28. Mitotic crossing-over by anticancer drugs in Saccharomyces cerevisiae strain D5
29. The anticlastogenic effect of various combinations of cysteamine, AET, HCT, and amino acids on chromosome damage by trenimon and bleomycin in human lymphocytes in vitro
30. Bleomycin-induced strand-scission of DNA: Mechanism of deoxyribose cleavage
31. Somatic mutation and recombination test in Drosophila melanogaster
32. Molecular mechanisms of chemical mutagenesis
33. Base substitutions, frameshifts, and small deletions constitute ionizing radiation-induced point mutations in mammalian cells
34. Carcinogenicity of bleomycin sulfate and peplomycin sulfate after repeated subcutaneous application to rats
35. Potentiation by hydroxyurea in G2-prophase of thiotepa- and bleomycin-induced chromosomal aberrations in Chinese hamster cells
36. Oxidative damage in DNA: Lack of mutagenicity by thymine glycol lesions
37. The chemistry of activated bleomycin
38. Heterogeneity in chromosome damage and repair rates after bleomycin in ataxia telangiectasia cells
39. Evidence for reactive oxygen species inducing mutations in mammalian cells
40. Single-strand and double-strand deoxyribonucleic acid breaks produced by several bleomycin analogues
41. Potentiation of cell killing by inhibitors of poly(adenosine diphosphate-ribose) synthesis in bleomycin-treated Chinese hamster ovary cells
42. Single-strand scission and repair of DNA in mammalian cells by bleomycin
43. X-ray-induced chromosome damage in live mammalian cells, and improved measurements of its effects on their colony-forming ability
44. Chemical modulation of bleomycin induced toxicity
45. Effects of caffeine on the frequencies of chromosomal aberrations and sister chromatid exchanges induced by chemical mutagens in root tips of Vicia faba
46. Bleomycin may be activated for DNA cleavage by NADPH-cytochrome P-450 reductase
47. Deoxyribonucleic acid (DNA) damage induced by bleomycin-Fe(II) in vitro: Formation of 8-hydroxyguanine residues in DNA
48. An active intermediate formed in the reaction of blcomycin-Fe(II) complex with oxygen
49. Preferential damage of active chromatin by bleomycin
50. Biochemical and cytological studies of bleomycin actions on chromatin and chromosomes
51. Sister chromatid exchanges in lymphocyte cultures of patients receiving chemotherapy for malignant disorders
52. A new Salmonella tester strain (TA102) with A·T base pairs at the site of mutation detects oxidative mutagens
53. Spontaneous and mutagen-induced deletions: Mechanistic studies in Salmonella tester strain TA102
54. Ethanol and acetaldehyde potentiate the clastogenicity of ultraviolet light, methyl methanesulfonate, mitomycin C and bleomycin in Chinese hamster ovary cells
55. Bleomycin-induced alkaline-labile damage and direct strand breakage of PM2 DNA
56. Properties of the initial reaction of bleomycin and several of its metal complexes with Ehrlich cells
57. Redox cycling of bleomycin-Fe(III) and DNA degradation by isolated NADH-cytochrome b5 reductase: involvement of cytochrome b5
58. DNA sequence determination of gamma-radiation-induced mutations of the hamster aprt locus
59. A comparison of induced sister chromatid exchange levels in Chinese hamster ovary cells and cultured human lymphocytes
60. Ataxia-telangiectasia: an inherited disorder of ionizing-radiation sensitivity in man
61. Bleomycin-induced mutation and recombination in Saccharomyces cerevisiae
62. Protective effects of 2-[(aminopropyl)amino]ethanethiol against bleomycin and nitrogen mustard-induced mutagenicity in V79 cells
63. Molecular mechanisms involved in the production of chromosomal aberrations. I. Utilization of Neurospora endonuclease for the study of aberration production in G2 stage of the cell cycle
64. Comparison of 6-thioguanine-resistant mutation and sister chromatid exchanges in Chinese hamster V79 cells with forty chemical and physical agents
65. On the origin of chromosomal aberrations in the human peripheral lymphocytes in vitro I. Experiments with Neurospora endonuclease and polyethylene glycol
66. A cytological test system to detect mutagen-induced DNA single-strand breaks: Posttreatment of G2 phase CHO cells with Neurospora endonuclease
67. Bleomycin in contrast to ionizing radiation induces extreme variation of DNA strand breakage from cell to cell
68. Cellular uptake and efflux of peplomycin in sensitive and bleomycin resistant subline of mouse lymphoma L5178Y cells
69. A replication model for sister-chromatid exchange
70. Mutagenic activity of anticancer drugs and the urine of rats given these drugs
71. Mutagenicity of bleomycins, phleomycins and tallysomycins in Salmonella typhimurium
72. Vitamin C intake influences the bleomycin-induced chromosome damage assay: implication for detection of cancer susceptibility and chromosome breakage syndromes
73. Catalytic release of DNA bases by oxidation-reduction of an iron-bleomycin complex
74. Bleomycin
75. Bleomycin-induced mutagenesis in repackaged lambda phage: Base substitution hotspots at the sequence C-G-C-C
76. A role for oxidative DNA sugar damage in mutagenesis by neocarzinostatin and bleomycin
77. DNA double-strand breaks and alkali-labile bonds produced by bleomycin
78. Bleomycin-induced mutagenesis of lambda phage in SOS-deficient and repair endonuclease-deficient Escherichia coli
79. Effect of apurinic/apyrimidinic endonucleases and polyamines on DNA treated with bleomycin and neocarzinostatin: Specific formation and cleavage of closely opposed lesions in complementary strands
80. Neocarzinostatin-induced DNA base release accompanied by staggered oxidative cleavage of the complementary strand
81. Structure of bleomycin-induced DNA double-strand breaks: Predominance of blunt ends and single-base 5′ extensions
82. Identification of the alkaline-labile product accompanying cytosine release during bleomycin-mediated degradation of d(CGCGCG)
83. Identification of the source of oxygen in the alkaline-labile product accompanying cytosine release during bleomycin-mediated oxidative degradation of d(CGCGCG)
84. Defective repair of DNA single- and double-strand breaks in the bleomycin- and X-ray-sensitive Chinese hamster ovary cell mutant, BLM-2
85. 2 with HeLa cells
86. Cross sensitivity to DNA damaging agents in radiation sensitive mutants of murine leukemia cells
87. The cytogenetic efficiency of the antitumor agents bleomycin and peplomycin is enhanced by the heart drug verapamil (isoptin)
88. Enhancement of the cytogenetic efficacy of the antitumor agent bleomycin by the calcium and calmodulin antagonist fendiline
89. Redox cycling of Fe(III)-bleomycin by NADPH-cytochrome P-450 reductase
90. Relationships between chromosome damage, cell cycle delay and cell killing induced by bleomycin or X-rays
91. Bleomycin hydrolase: Molecular cloning, sequencing and biochemical studies reveal membership in the cysteine proteinase family
92. Kinetics and repair of bleomycin-induced chromosome damage in quiescent normal human fibroblasts and human mononuclear blood cells
93. Some chemotherapeutic agents are capable of inducing aneuploidy, translocation, and breakage in the spermatogonial stem cells of treated mice
94. Bleomycin-induced DNA damage and repair in human cells permeabilized with lysophosphatidylcholine
95. Comparison of the mutagenic responses of 12 anticancer drugs at the hypoxanthineguanine phosphoribosyl transferase and adenosine kinase loci in Chinese hamster ovary cells
96. Mutagenic responses of thirteen anticancer drugs on mutation induction at multiple genetic loci and on sister chromatid exchanges in Chinese hamster ovary cells
97. Interaction of bleomycin, hyperthermia and a calmodulin inhibitor (trifluoperazine) in mouse cells
98. Interaction of bleomycin, hyperthermia and a calmodulin inhibitor (trifluoperazine) in mouse cells: II. DNA damage, repair and chromatin changes
99. The relationship between DNA and chromosome damage after bleomycin treatment: dose response measurements
100. Induction of sister chromatid exchanges in Chinese hamster cells by antitumor agents and its relation to chromosome aberrations
101. Isolation of cell cycle-dependent gamma ray-sensitive Chinese hamster ovary cell
102. Bleomycin-induced DNA lesions at mutational hot spots: implications for the mechanism of double strand cleavage
103. Effect of in vitro cleavage of apurinic/apyrimidinic sites on bleomycin-induced mutagenesis of repackaged lambda phage
104. Mechanisms of bleomycin-induced DNA degradation
105. Structure of the alkali-labile product formed during iron(II)-bleomycin-mediated DNA strand scission
106. Interaction of bleomycin with DNA
107. Aneuploidy induced by bleomycin in oocytes of Drosophila melanogaster: studies with the aneuploidy pattern method
108. Mutagenic effects of bleomycin in Drosophila melanogaster
109. Studies on the mechanism of antitumor effect of bleomycin on squamous cell carcinoma
110. Mutagenicity of anthracycline glycosides and bleomycins in Salmonella assay
111. Bleomycin-induced structural chromosomal aberrations in spermatogonia and bone-marrow cells of mice
112. Absence of treatment-induced second neoplasms after ABVD in Hodgkin's disease
113. Enhancement of bleomycin toxicity and mutation at the APRT locus in CHO cells
114. Hyperthermic enhancement of chromosome damage and lack of effect on sister chromatid exchanges induced by bleomycin in Chinese hamster cells in vitro
115. Genetic toxicology of bleomycin
116. Hyperthermic potentiation of chromosome aberrations by anticancer antibiotics
117. Resistance and cross-resistance to chromosome damage in human blood lymphocytes adapted to bleomycin
118. Use of computerized data listings and activity profiles of genetic and related effects in the review of 195 compounds
119. Ethyl methane sulfonate- and bleomycin-generated deletion mutations at the HPRT locus in xeroderma pigmentosum complementation group D fibroblasts
120. Fragile sites are targets of diverse mutagens and carcinogens
121. Effects of 3-aminobenzamide on Chinese hamster cells treated with thymidine analogues and DNA-damaging agents: Chromosomal aberrations, mutations and cell-cycle progression